Merck Sees Aggressive Bullish Options Activity as $2M in Call Premiums Target Upside Above $135

By TrendSpider Editor

Merck & Company, Inc. (MRK) is drawing significant attention in the options market today, with six unusual call contracts generating a combined $1,995,198 in total premium as shares trade at $128.925, up 0.87% on the session. The most striking contract of the day is a September 18 $145 call that

Merck Sees Aggressive Bullish Options Activity as $2M in Call Premiums Target Upside Above $135

Merck & Company, Inc. (MRK) is drawing significant attention in the options market today, with six unusual call contracts generating a combined $1,995,198 in total premium as shares trade at $128.925, up 0.87% on the session. The most striking contract of the day is a September 18 $145 call that printed 10,139 contracts against open interest of just 1,427, representing a staggering 711% of existing open interest and suggesting a large directional bet on a meaningful move higher. With MRK trading near the upper end of its 52-week range of $77.58 to $135.05, the positioning implies some traders are anticipating a breakout above prior highs in the weeks ahead.

Key Drivers of the MRK Stock Move

The forward setup for MRK looks constructive on a technical basis, with the stock reclaiming territory near its 52-week high and options traders stacking bullish bets at multiple strike levels and expirations. The clustering of activity at the $135 and $145 strikes for September suggests that sophisticated market participants are not just speculating on a near-term pop but may be positioning for a catalyst that could drive shares through prior resistance. The presence of a longer-dated $155 strike for March 2027 adds a layer of conviction to the broader bullish thesis, pointing to expectations of continued momentum into early next year.

MRK Unusual Options Activity

MRK Seasonality

August and September historically represent an active period for pharmaceutical stocks as companies navigate mid-year pipeline updates and conference season, which can serve as catalysts for sharp directional moves. The clustering of September expiration calls today aligns with a window in which major drug companies often present clinical data or guidance updates that can move shares materially.

MRK Relative Performance

MRK is up 0.87% on the session and trading at $128.925, positioning it near the top of its 52-week range between $77.58 and $135.05. The stock has recovered substantially from its 52-week low, reflecting renewed investor interest in large-cap pharma, and today's price action combined with aggressive call buying suggests MRK is outperforming on a relative basis compared to where it spent much of the past year.

More on MRK

Latest Market News